Results 131 to 140 of about 4,764 (176)

A novel risk prediction model incorporating triglyceride-glucose-body mass index for in-hospital mortality in hypertensive patients with HFmrEF. [PDF]

Lipids Health Dis
Guo Q, Wei M, Shang S, Lv H, Zukela TH, Xu Y, Gu X, Lu Y, Tang B.   +8 more
europepmc   +1 more source

Baseline vs. on-treatment heart failure with preserved ejection fraction (HFpEF) in a real world cardio-oncology clinic: observational analysis of cancer therapy-related cardiovascular toxicity incidence and cancer treatment implications. [PDF]

Front Cardiovasc Med
von Kemp B, Galloo X, Roosens B, Neyns B, Schots R, De Ridder M, Cosyns B.   +6 more
europepmc   +1 more source

Contemporary Guideline-Directed Medical Therapy for Heart Failure in the United States: The EMPACE Study. [PDF]

J Am Heart Assoc
Greene SJ, Adam A, Schmedt N, Carlsen C, Brand M, Davies E, Jouaville Abrouk LS, Prochaska JH, Tran P, Alhamdow A.   +9 more
europepmc   +1 more source

Baseline characteristics of patients enrolled in the AZIMUTH trial: an e-health-integrated, smartphone app-based model of care for heart failure patients. [PDF]

Eur Heart J Open
D'Amario D, Paglianiti DA, Laborante R, Elia S, Rizzo G, Giubilato S, Catalano M, Amico F, Volterrani M, Restivo A, Patarnello S, Kyriazakos S, Luraschi A, Delvinioti A, Tomassini F, Kostopoulou K, Iaconelli A, Incaminato E, Canonico F, Gorini M, Marcoli S, Bartoli V, Griffiths T, Fenici P, Cesario A, Patti G, Crea F.   +26 more
europepmc   +1 more source

Finerenone in mildly reduced or preserved ejection fraction and chronic kidney disease: a narrative review. [PDF]

Egypt Heart J
Faheem MSB, Qurat Ul Ain H, Rauf A, Faheem Q, Najmi OEM.   +4 more
europepmc   +1 more source

Translating the 2023 Malaysian Heart Failure Clinical Practice Guidelines (5th Edition) into primary care practice. [PDF]

Malays Fam Physician
Loo SY, Wong PF, Low TL, Loke YY, Kiew LB, Mohamad MSF.   +5 more
europepmc   +1 more source

Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical Trial.

JAMA Cardiol
Lu H, Kosztin A, Claggett BL, Foà A, Pabón MA, Desai AS, Jhund PS, Henderson AD, Merkely B, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Amarante F, Saarinen R, De Sanctis Y, Glasauer A, McMurray JJV, Vaduganathan M, Solomon SD.   +21 more
europepmc   +1 more source

SGLT2 INHIBITORS IN HFPEF AND HFMREF: A COMPREHENSIVE PRISMA SYSTEMATIC REVIEW

openaire   +1 more source